- Home
- TNGX vs CLMT Comparison
TNGX vs CLMT Comparison
Compare TNGX & CLMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TNGX | CLMT |
|---|---|---|
| Founded | 2014 | 1916 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.4B |
| IPO Year | 2020 | 2024 |
Fundamental Metrics
Financial Performance| Metric | TNGX | CLMT |
|---|---|---|
| Price | $23.47 | $49.04 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 6 |
| Target Price | $44.88 | ★ $53.40 |
| AVG Volume (30 Days) | ★ 3.5M | 1.3M |
| Earning Date | 11-03-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 26.89 | ★ 85.39 |
| EPS | ★ N/A | N/A |
| Revenue | $62,384,000.00 | ★ $4,137,100,000.00 |
| Revenue This Year | N/A | $19.25 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 48.29 | N/A |
| 52 Week Low | $7.12 | $17.85 |
| 52 Week High | $34.39 | $59.87 |
Technical Indicators
Market Signals| Indicator | TNGX | CLMT |
|---|---|---|
| Relative Strength Index (RSI) | 47.72 | 33.58 |
| Support Level | $20.46 | $45.73 |
| Resistance Level | $25.68 | $51.50 |
| Average True Range (ATR) | 1.78 | 2.39 |
| MACD | 0.35 | -1.05 |
| Stochastic Oscillator | 33.57 | 8.35 |
Price Performance
Historical ComparisonAbout TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About CLMT Calumet Specialty Products Partners L.P.
Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.